Muccini C, Gianotti N, Lolatto R, Nozza S, et al. CD4+/CD8+ improvement after switch from a second-generation integrase inhibitor regimen to long-acting cabotegravir and rilpivirine. AIDS 2024;38:1890-1892.
PMID: 39325006